Form: 10-Q/A

Quarterly report pursuant to Section 13 or 15(d)

February 28, 2023

00018687262022Q2true--12-3100018687262022-01-012022-06-3000018687262022-06-30xbrli:shares
Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
________________________
FORM 10-Q/A
(Amendment No. 1)
_____________________
(Mark One)
    QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 2022
or
    TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from __________ to __________
Commission File Number  001-40860                         
________________________
Olaplex Holdings, Inc.
(Exact name of registrant as specified in its charter)
________________________
Delaware 87-1242679
(State or other jurisdiction of
incorporation or organization)
(I.R.S. Employer
Identification No.)
Address not applicable1
(Address of principal executive offices and zip code)
(310) 691-0776
(Registrant’s telephone number, including area code)
________________________
Securities registered pursuant to Section 12(b) of the Act:
Title of Each Class
Trading Symbol(s)
Name of each exchange on which registered
Common stock, par value $0.001 per share OLPX Nasdaq Global Select Market
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes      No  
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes      No  
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large Accelerated Filer Accelerated Filer
Non-accelerated Filer Smaller reporting company
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  
Indicate by check mark whether the registrant is a shell company (as defined by Rule 12b-2 of the Exchange Act).    Yes      No  
As of July 29, 2022, registrant had 649,087,823 shares of common stock, par value $0.001 per share, outstanding.
1 Olaplex Holdings, Inc. is a fully remote company. Accordingly, it does not maintain a principal executive office.


EXPLANATORY NOTE

Olaplex Holdings, Inc. (the “Company”) filed its Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2022 with the U.S. Securities and Exchange Commission (the “SEC”) on August 9, 2022 (the “Original Filing”). The Company is filing this Amendment No. 1 on Form 10-Q/A (this “Amendment”) solely to include certain disclosures required to be included in Item 5(a) of Part II of Form 10-Q. In accordance with Rule 12b-15 under the Securities Exchange Act of 1934, as amended, Part II, Item 5 “Other Information” of the Original Filing is hereby amended and restated in its entirety. This Amendment does not amend or otherwise update any other information in the Original Filing. This Amendment should be read in conjunction with the Original Filing and the Company’s other filings made with the SEC subsequent to August 9, 2022 and does not modify or update the Original Filing or the disclosures made therein in any way other than as described above. The Original Filing, as amended by the Amendment, continues to speak as of the date of the Original Filing, and the Company has not updated any of the disclosures contained herein to reflect events that have occurred since the date of the Original Filing.
PART II - OTHER INFORMATION

ITEM 5. OTHER INFORMATION

On June 27, 2022, pursuant to Section 14 of the Manufacturing Services Agreement (“Agreement”), dated January 1, 2020, by and between the Company and Cosway Company Inc. (“Cosway”), the Company notified Cosway that it intended to negotiate with Cosway the terms of a new manufacturing services agreement to replace the Agreement and, in connection therewith, was exercising its right to elect that the Agreement expire in accordance with its terms, effective as of January 1, 2023.
2


ITEM 6. EXHIBITS


Exhibit Number Description
31.1
31.2
101.INS Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document.
101.SCH Inline XBRL Taxonomy Extension Schema Document
101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
# Indicates a management contract or compensation plan, contract or arrangement.
† This certification will not be deemed “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liability of that section. Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent specifically incorporated by reference into such filing.
3


SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
OLAPLEX HOLDINGS, INC.
   
By: /s/ JuE Wong
February 28, 2023 Name: JuE Wong
Title: President and Chief Executive Officer
(Principal Executive Officer)
By: /s/ Eric Tiziani
February 28, 2023 Name: Eric Tiziani
Title: Chief Financial Officer
(Principal Financial Officer)
4